Detection of synthetic cannabinoid adulteration in the unregulated drug supply in three Canadian settings.
Lianping TiSamuel TobiasNazlee MaghsoudiMichael John MilloyKaren McDonaldAaron ShapiroDaniel BeriaultCristiana StefanMark LysyshynDaniel WerbPublished in: Drug and alcohol review (2020)
As point-of-care technologies failed to detect these compounds in many occasions, our findings demonstrate the importance of laboratory confirmatory analysis to identify NPS. Given the high risk of harm associated with the consumption of synthetic cannabinoids, further research should investigate the reasons for adulteration.